Brain Structure Assists in Immune Response, According to Penn Vet StudyJanuary 29, 2009PHILADELPHIA -- For the first time, a team of researchers at the University of Pennsylvania School of Veterinary Medicine have imaged in real time the body's immune response to a parasitic infection in the brain. The complete findings, published in the current issue of the journal Immunity, provide unexpected insights into how immune cells are regulated in the brain and have implications for treatment of any inflammatory condition that affects the brain. Toxoplasma, a common parasite of humans, is found in the brains of approximately 30 percent of the population. Yet, because the brain lacks its own lymphatic system for localized immune response and the blood brain barrier limits antibody entry, researchers have found it provides unique challenges for the immune system to control local infection. Therefore, little is known about the processes by which T cells access the central nervous system during toxoplasma infection or how the immune system keeps this parasite in check. In this Penn study, researchers aimed to better understand how the immune system is able to control infection in the brain. Using recent advances in two-photon microscopy that allow the visualization of T-cell populations in the brain, Chris Hunter's lab focused on the visualization of effector CD8+ T cells during toxoplasmic encephalitis. "We found, quite unexpectedly, that the movement of infiltrating T cells was closely associated with an infection-induced reticular system of fibers in the brain," lead author Emma Wilson said. "These structures were not present in normal brain tissue." "This observation suggests that in the brain, specialized structures are induced by inflammation that guide migration of T cells in this immune-privileged environment and allow them to perform a search-and-destroy type of mission required to find abnormal cells or microbes with the brain," Hunter, professor and chair of the Department of Pathobiology at Penn Vet, said. The study was supported by a grant from the National Institutes of Health and the Commonwealth of Pennsylvania. The study was performed by Wilson of Penn, now at the Department of Biomedical Sciences at the University of California, Riverside; Tajie H. Harris, Beena John, Elia Tait, Marion Pepper and Hunter of the Department of Pathobiology at Penn Vet; Wolfgang Weninger, Paulus Mrass and E. John Wherry of The Wistar Institute (Weninger and Mrass are now at the Centenary Institute for Cancer Medicine and Cell Biology in Sydney); Florence Dzierzinski of the Institute of Parasitology at McGill University; Philip G. Haydon of the Department of Neuroscience at Tufts University; Gregory F. Wu and Terri M. Laufer of the Department of Medicine at the University of Pennsylvania School of Medicine; and David Roos of the Department of Biology at Penn. University of Pennsylvania |
|||||||||||||||||||||
| Related Immune Response Current Events and Immune Response News Articles New Notre Dame study provides insights into the molecular basis of tumor cell behavior A new study by a team of researchers led by Crislyn D'Souza-Schorey, associate professor of biological sciences at the University of Notre Dame, sheds light on the molecular basis by which tumor cells modulate their surroundings to favor cancer progression. New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. Common Pain Relievers May Dilute Power of Flu Shots With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. Study reveals a 'missing link' in immune response to disease The immune system's T cells have the unique responsibilities of being both jury and executioner. They examine other cells for signs of disease, including cancers or infections, and, if such evidence is found, rid them from the body. Precisely how T cells shift so swiftly from one role to another, however, has been a mystery. Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Bacteria 'launch a shield' to resist attack Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system. Scientists use world's fastest supercomputer to create the largest HIV evolutionary tree Supporting Los Alamos National Laboratory's role in the international Center for HIV/AIDS Vaccine Immunology (CHAVI) consortium, researchers are using the Roadrunner supercomputer to analyze vast quantities of genetic sequences from HIV infected people in the hope of zeroing in on possible vaccine target areas. Study shows how carbon nanotubes can affect lining of the lungs Carbon nanotubes are being considered for use in everything from sports equipment to medical applications, but a great deal remains unknown about whether these materials cause respiratory or other health problems. More Immune Response Current Events and Immune Response News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||